ARG1 and psoriasis: The engineered nor@MSC-EVs inhibited the NF-κB pathway by targeting the Arg1/polyamine-mediated dendritic cells (DCs)/ T helper 17 (Th17) axis, reducing T helper 1 (Th1) and Th17 cell differentiation and alleviating skin lesions in a psoriasis mouse model [68].